WTC
RXRX icon

WhitTier Trust Company’s Recursion Pharmaceuticals RXRX Stock Holding History

WhitTier Trust Company’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.3K Buy
2,000
+1,000
+100% +$3.86K ﹤0.01% 1120
2025
Q4 		$4.55K Hold
1,000
– – ﹤0.01% 1083
2025
Q3 		$5.49K Buy
+1,000
New +$5.25K ﹤0.01% 1065

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WhitTier Trust Company's RXRX Position: Q1 2026 in Review

WhitTier Trust Company increased its Recursion Pharmaceuticals (RXRX) stake by 100% in Q1 2026, buying an estimated $3.86K and bringing the position to 2,000 shares worth $6.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1120.

WhitTier Trust Company first reported a position in RXRX in Q3 2025 and has held it in 3 quarters since. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • WhitTier Trust Company held 2,000 shares of Recursion Pharmaceuticals worth $6.3K as of Q1 2026.
  • WhitTier Trust Company bought 1,000 Recursion Pharmaceuticals shares in Q1 2026, an estimated $3.86K.
  • Recursion Pharmaceuticals made up ﹤0.01% of WhitTier Trust Company's portfolio in Q1 2026, its #1120 holding.
  • WhitTier Trust Company first reported a position in Recursion Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on WhitTier Trust Company's 13F filing for Q1 2026, filed 28 Apr 2026.